IceCure Medical Ltd. (ICCM) stock
ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.73+0.03 (+4.21%)
Close on Nov 13, 2026Market cap $2.50MP/E 0.1Yield –
IceCure Medical statistics
83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.21
- 4.81
Enterprise valuationIndustry
- EV / Sales
- -2.81
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 25.0%
- 3.32%
- Shares Held by Institutions
- 3.83%
- 60.5%
Short sellingIndustry
- Short Interest
- 56,133
- –
- Short Interest Change
- 33.1%
- -2.57%
- Short % of Shares Outstanding
- 1.64%
- 3.98%
- Days to Cover
- 1.00
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $22.50
- –
- 52-Week Low
- $0.65
- –
- 20-Day Moving Average
- $0.88
- –
- 50-Day Moving Average
- $1.35
- –
- 200-Day Moving Average
- $6.99
- –
- Average True Range (14)
- $0.12
- –
- Price Change (1 Week)
- 7.24%
- 0.99%
- Price Change (1 Month)
- -29.8%
- -3.52%
- Price Change (3 Months)
- -74.1%
- -7.86%
- Price Change (6 Months)
- -89.4%
- -1.12%
- Price Change (YTD)
- -96.0%
- -2.92%
- Price Change (1 Year)
- -96.6%
- -1.37%
- Price Change (3 Years)
- -96.7%
- 3.24%
- Price Change (5 Years)
- -99.6%
- -50.4%
- Price Change (10 Years)
- -87.8%
- 58.9%
- Average Volume (10 Days)
- 149,851
- –
- Average Volume (20 Days)
- 121,151
- –
- Average Volume (90 Days)
- 135,382
- –
- Relative Volume
- 0.17
- 0.76
- Relative Strength Index (14)
- 29.4
- 46.7
- Volatility (1 Year)
- 232.0%
- 64.2%
- Beta (5 Years)
- 0.69
- 1.04
MarginsIndustry
- EBITDA Margin
- -446.7%
- -2.52%
- FCF Margin
- -432.4%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- -203.7%
- -17.3%
- Return on Assets (ROA)
- -106.4%
- -12.3%
- Return on Capital Employed (ROCE)
- -126.7%
- -8.13%
Financial positionIndustry
- Current Ratio
- 2.87
- 2.49
- Quick Ratio
- 2.15
- 1.53
- Debt / Equity
- 0.00
- 0.42
GrowthIndustry
- Revenue Growth (YoY)
- 2.67%
- 9.42%
- EPS Growth (YoY)
- -20.0%
- 15.1%
- Revenue Growth (3Y CAGR)
- 3.08%
- 7.08%
- Revenue Growth (5Y CAGR)
- -2.67%
- 11.8%
- EPS Growth (3Y CAGR)
- -19.5%
- 3.11%
- EPS Growth (5Y CAGR)
- 1.76%
- 7.64%
EfficiencyIndustry
- Asset Turnover
- 0.24
- 0.59
- Inventory Turnover
- 0.88
- 2.20
- Revenue Per Employee
- $50.43K
- $331.99K
- Profits Per Employee
- -$224.73K
- -$46.47K
- Employee Count
- 67
- 193
- WACC
- 8.51%
- 9.91%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $12.01M
- $3.95M
- Net Cash Per Share
- $3.51
- $0.26
- Equity (Book Value)
- $11.90M
- $63.80M
- Book Value Per Share
- $3.47
- $3.26
- Tangible Book Value
- $11.90M
- $11.61M
- Working Capital
- $10.86M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$36.00K
- -$3.94M
- FCF Per Share
- -$4.26
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -601.9%
- -4.76%
- FCF Yield
- -584.0%
- 0.28%
Scores and fair valueIndustry
- Graham Number
- $23.71
- $38.11
- Graham Upside
- 3148.6%
- -56.1%
- Altman Z-Score
- -11.84
- 2.47
- Piotroski F-Score
- 4
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ICCM | S&P 500 | Difference | ICCM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -33.6% | -3.0% | −30.6 pts | ||
| 3 months | -75.7% | -2.8% | −72.9 pts | ||
| Year to date | -96.0% | +11.5% | −107.5 pts | ||
| 1 year | -96.6% | +13.5% | −110.0 pts | ||
| 3 years | -96.7% | +77.7% | −174.4 pts | -67.9% | +21.1% |
| 5 years | -99.6% | +72.6% | −172.2 pts | -67.3% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M ICCM shares were sold short on Oct 30, 2026, up 33.1% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 40.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 56,133 | +33.1% | 91,935 | 1.0 |
| Oct 15, 2026 | 42,182 | -19.1% | 229,602 | 1.0 |
| Sep 30, 2026 | 52,159 | -49.2% | 123,547 | 1.0 |
| Sep 15, 2026 | 102,639 | -4.7% | 99,227 | 1.0 |
| Aug 31, 2026 | 107,730 | +164.2% | 218,702 | 1.0 |
| Aug 14, 2026 | 40,780 | +8.7% | 82,427 | 1.0 |
| Jul 31, 2026 | 37,525 | -66.3% | 74,572 | 1.0 |
| Jul 15, 2026 | 111,279 | -65.8% | 298,100 | 1.0 |
| Jun 30, 2026 | 325,222 | +263.7% | 19,668,919 | 1.0 |
| Jun 15, 2026 | 89,416 | -87.6% | 160,692 | 1.0 |
| May 29, 2026 | 718,392 | -44.2% | 759,175 | 1.0 |
| May 15, 2026 | 1,286,399 | +17.5% | 528,309 | 2.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?